The following table shows the list of Horizon 2020 projects developed by "CELLPROTECT NORDIC PHARMACEUTICALS AB". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | BOOSTB4 | H2020-EU.3.1.3. | participant | 549˙781.00 | 2016-01-01 | 696 |
totale | 549˙781.00 |
This organization collaborated with partners in 4 countries.
Within the project BOOSTB4 this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | SE | NHE | NORDIC HEALTH ECONOMICS AB (PRC) |
participant | UK | A2F | A2F ASSOCIATES LIMITED (PRC) |
participant | SE | MEDSCINET | MEDSCINET AB (PRC) |
participant | UK | GOSH | GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST (PUB) |
participant | UK | EURAM | EURAM LIMITED (PRC) |
participant | DE | UKK | KLINIKUM DER UNIVERSITAET ZU KOELN (HES) |
participant | SE | ULUND | LUNDS UNIVERSITET (HES) |
participant | NL | UMC UTRECHT | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
coordinator | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | ULEIC | UNIVERSITY OF LEICESTER (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |